Fresenius Medical Care Reports Lower Mortality With HDF
BAD HOMBURG, GERMANY, Aug 27, 2026 Fresenius Medical Care has announced the publication of a large multinational real-world evidence...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
BAD HOMBURG, GERMANY, Aug 27, 2026 Fresenius Medical Care has announced the publication of a large multinational real-world evidence...
Osaka, Japan and Bridgewater, New Jersey, August 4, 2026 NIPRO CORPORATION, through its U.S.-based subsidiary NIPRO Medical Corporation, has...
PLANO, Texas, July 30, 2026 U.S. Renal Care (USRC) is expanding the availability of medium cut-off (MCO) dialyzers to...
BAD HOMBURG, Germany, Dec. 10, 2025 — Fresenius Medical Care, the world’s leading provider of products and services for...
